What this page is / is not
If you or someone you love is facing advanced cancer, it is normal to search for clear answers. This page exists to explain one published research concept in everyday language so you can take better questions to your own care team.
- It is: educational research information for patients, caregivers, and curious readers.
- It is not: a clinic, a treatment offer, an enrollment form, or a way to “get TOL.”
- It does not: diagnose, recommend therapy, or replace a licensed oncologist.
What Targeted Osmotic Lysis means
Targeted Osmotic Lysis (TOL) is a published research concept. In plain English, the published hypothesis describes a research idea aimed at solid tumor cells that carry many more voltage-gated sodium channels than normal cells.
Researchers describe a sequence in laboratory and related models: stimulate those sodium channels, block the cell’s sodium pumps, and disrupt the cell’s water balance until the cell ruptures — a process called osmotic lysis. That is a research hypothesis about how cancer cells differ from normal cells. It is not a product pitch, and it is not a promise of benefit in people.
Investigational only The language on this page describes published science education, not available care.
What the published record covers
The published record discussed on these sites includes laboratory work, veterinary / companion-animal studies, and limited human case reports. Evidence types are labeled on the FixCancer.org literature stack. As of this page’s last update:
- Most published evidence is preclinical or veterinary.
- Human evidence is limited to individual case reports; case reports cannot establish effectiveness.
- There are no published randomized trials of TOL.
- There are no human TOL trials registered on ClinicalTrials.gov.
- Safety and effectiveness in humans are not established.
For labeled publications and evidence context, start with the FixCancer.org literature stack. FixCancers.com is the plain-language companion and does not duplicate every citation here.
TOL is investigational. It is not FDA-approved for any indication. It is not available as a treatment here or through these sites. These sites do not enroll, schedule, or provide TOL therapy, and they do not claim TOL cures, fixes, or eliminates cancer.
Questions for your oncology team
Care decisions belong with a licensed oncologist who knows the full medical picture. Useful education questions (not eligibility screening) include:
- What molecular profiling has been done on this tumor?
- What clinical trials match the molecular profile?
- How do I tell investigational research from FDA-approved care?
- Where should we look on ClinicalTrials.gov for registered studies?
Authoritative starting points for care decisions: cancer.gov and ClinicalTrials.gov.
Frequently asked questions
What is Targeted Osmotic Lysis (TOL)?
TOL is a published research concept studied in laboratory and related scientific literature. These pages explain that research in plain language. They do not offer TOL as care.
Is TOL FDA-approved?
No. Targeted Osmotic Lysis is investigational and is not FDA-approved for any indication.
Can I get TOL treatment through FixCancers or FixCancer?
No. TOL is not available as treatment through these sites. We do not enroll, schedule, or provide TOL therapy.
Is TOL a cure for cancer?
No. These sites do not claim TOL cures, fixes, or eliminates cancer. Safety and effectiveness in humans are not established as approved care.
Why does clear education matter for this topic?
People searching for patient-facing TOL explanations need a calm, claims-light answer. This page’s job is honest research education — not to attack other sources, and not to sell treatment access.
Where can I read the literature?
Start with the FixCancer.org literature stack for labeled publications. For personal care decisions, use your licensed oncologist and trusted sources such as cancer.gov and ClinicalTrials.gov.
How do I contact you?
Request a call / contact only via the intake call form on FixCancers.com. Contact is for education questions — not treatment access, eligibility, or enrollment.
Have education questions?
Under stress, a short conversation can help you sort questions for your own care team. Request a 15-minute intake call — contact only. We’ll call you back about education questions. This is not a clinic visit, not enrollment, and not a treatment offer.
Request a call Read the literature stackReferences
- National Cancer Institute. What Is Cancer / Types of Cancer Treatment / Clinical Trials. cancer.gov
- U.S. National Institutes of Health. ClinicalTrials.gov. clinicaltrials.gov
- FixCancer.org. Educational research overview and labeled TOL literature. fixcancer.org/#literature